Consumption of drugs for Alzheimer's disease on the Brazilian private market.

Evani Leite de Freitas Sabrina Calil-Elias Rafael Santos Erbisti Branca Grinberg-Weller Elaine Silva Miranda

Published in: Revista de saude publica (2023)

The consumption of medicines indicated to treat Alzheimer's disease tripled in Brazil between 2014 and 2020, which may relate to the increase in the prevalence of the disease in the country, greater access to health services, and inappropriate use. This challenges managers and healthcare providers due to population aging and the increased prevalence of chronic-degenerative diseases.

Keyphrases

healthcare
risk factors
health insurance
cognitive decline
social media
drug induced